News

Limited benefits for osteoarthritis patients from acetaminophen


 

References

Acetaminophen is ineffective for short-term treatment of low back pain and has limited benefit for patients with knee or hip osteoarthritis, according to a systematic review of randomized, controlled trials by Gustavo Machado and his associates.

In three trials, there was no significant difference between acetaminophen and a placebo on pain relief for people with low back pain. In 10 trials involving patients with hip or knee osteoarthritis, acetaminophen provided a statistically significant benefit over placebo, but the effect was small. There were similar rates of adverse side effects, medication adherence, and use of rescue medication in both groups.

The review also “found higher risk of abnormal results on liver function tests in patients taking [acetaminophen], though the clinical implications of this are uncertain,” the investigators said.

Find the full review in the BMJ (doi:10.1136/bmj.h1225).

Recommended Reading

Sinus headaches
MDedge Neurology
NIH report on long-term opioid treatment cites lack of data, research needs
MDedge Neurology
CDC: Opioid use high among reproductive age women
MDedge Neurology
No pain benefit found for IV acetaminophen vs. oral in the neuro ICU
MDedge Neurology
Abuse-deterrent formulation of extended-release hydrocodone approved
MDedge Neurology
Tips for managing pregnant patients with migraine
MDedge Neurology
VIDEO: Ask patients about metal-on-metal hip implants
MDedge Neurology
Abuse-Deterrent Formulation of Extended-Release Hydrocodone Receives FDA Approval
MDedge Neurology
Newly isolated spider venom compounds could relieve chronic pain
MDedge Neurology
Conference News Update—American Association for the Advancement of Science
MDedge Neurology